Where do stem cells come from for therapy is a common question because the source can affect how a treatment is discussed and why a clinic may recommend one option over another. In regenerative medicine, stem cells used in orthopedic care are usually collected from a patient’s own body or from donated birth tissue. Common sources include bone marrow, adipose tissue, and umbilical cord tissue. Each source has different collection methods, cell characteristics, and practical considerations. For knee pain research, it is also important to know that regenerative injection therapy is investigational per FDA, so it should be presented as an educational option, not a guaranteed solution. If you are comparing choices for knee pain in Florida, understanding the source is a useful first step before you decide whether to schedule a consultation or a screening.
Where do stem cells come from for therapy?
Stem cells for therapy can come from a few main sources. In orthopedic regenerative care, the most common are bone marrow, adipose tissue, and umbilical cord tissue. Bone marrow stem cells are usually taken from the pelvis. Adipose stem cells come from fat tissue, often collected through a minor procedure. Umbilical cord stem cells come from donated birth tissue that is screened and processed by a lab. The source matters because it affects how the sample is obtained and how it is prepared.
ContextWhy do clinics discuss bone marrow, fat, and cord sources differently?
Clinics discuss stem cell sources differently because each source has different practical tradeoffs. Bone marrow stem cells are often considered for orthopedic uses because the collection is familiar in medicine. Adipose stem cells may be discussed when a larger tissue volume is wanted. Umbilical cord stem cells are not taken from your own body, so they are handled differently and depend on donor screening and processing. A good discussion should focus on source, safety, and whether the approach fits your history.
EvidenceWhat does the evidence say about stem cell therapy for knees?
The evidence base is still developing. A Cochrane 2025 systematic review evaluated 25 trials with 1,341 participants and found that regenerative injection evidence remains limited and uncertain for knee osteoarthritis. That is why this type of care is treated as investigational rather than a proven cure. FDA guidance also matters here, because clinics should not imply guaranteed outcomes. You should ask how a provider explains the evidence, risks, and realistic goals before any treatment decision.
CostHow much does stem cell therapy cost for a knee?
Cost is a major practical issue because regenerative injection therapy is often not covered by insurance. A common self-pay range is $3,000 to $8,000 per knee, depending on the source, the procedure, and what is included in the visit. If you are comparing options, ask whether the price covers evaluation, imaging review, injection procedure, follow-up visits, and any lab processing. Clear pricing helps you compare care more responsibly.
Next StepWhat should you do next if you are considering treatment?
If you are comparing stem cell sources for knee pain, start with an evaluation that explains whether your symptoms fit regenerative care, physical therapy, or another approach. At Revive by MWS in Leesburg, you can ask about a free knee screening to review your history and discuss next steps. The clinic is located at 920 E Dixie Ave Suite A, Leesburg, FL 34748, and the phone number is (352) 559-1901.
Key FactsKey Facts to Remember
Book Your Free Knee Screening
The free knee screening is available to a limited number of qualifying patients each month at Revive by MWS, 920 E Dixie Ave Suite A, Leesburg, FL 34748. Includes imaging review, physical exam, and a clear conversation about whether regenerative therapy fits your case.
Common Questions
Sometimes. Bone marrow stem cells and adipose stem cells are commonly taken from your own body. Umbilical cord stem cells come from donated birth tissue instead. The source changes how the material is collected, processed, and discussed in clinic.
Bone marrow and adipose tissue are the most commonly discussed sources in orthopedic regenerative care. The choice depends on the clinic’s protocol, your anatomy, and the reason for treatment. A consultation should explain why one source is being considered over another.
No. Umbilical cord stem cells come from donated birth tissue after delivery, not from a developing fetus. They are screened and processed under specific protocols. You should ask how the tissue is sourced, handled, and documented before considering any treatment.
Regenerative injection therapy for knee arthritis is generally considered investigational. That means it should be discussed as an educational and emerging option, not a proven standard treatment. You should be cautious about any claim that suggests guaranteed outcomes or a cure.
It may be worth discussing if you want to explore non-surgical options for knee pain and understand the source, cost, and evidence first. A screening can help you compare this approach with physical therapy, medications, or surgery based on your goals.
Sources
Education only. Not medical advice. Regenerative injections for knee osteoarthritis are not FDA-approved and are considered investigational. Individual results vary. Consult a licensed medical provider about your specific case.